Stratos Wealth Partners’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-8,859
| Closed | -$227K | – | 1458 |
|
|
2024
Q3 | $227K | Sell |
8,859
-1,442
| -14% | -$36.9K | ﹤0.01% | 1278 |
|
|
2024
Q2 | $242K | Sell |
10,301
-2,051
| -17% | -$48.2K | ﹤0.01% | 1183 |
|
|
2024
Q1 | $355K | Sell |
12,352
-1,745
| -12% | -$50.2K | 0.01% | 1025 |
|
|
2023
Q4 | $463K | Sell |
14,097
-1,531
| -10% | -$50.2K | 0.01% | 897 |
|
|
2023
Q3 | $435K | Buy |
15,628
+7,528
| +93% | +$210K | 0.01% | 871 |
|
|
2023
Q2 | $276K | Sell |
8,100
-1,027
| -11% | -$35K | 0.01% | 993 |
|
|
2023
Q1 | $274K | Sell |
9,127
-1,375
| -13% | -$41.3K | 0.01% | 904 |
|
|
2022
Q4 | $296K | Sell |
10,502
-282
| -3% | -$7.96K | 0.01% | 896 |
|
|
2022
Q3 | $354K | Sell |
10,784
-4,298
| -28% | -$141K | 0.01% | 802 |
|
|
2022
Q2 | $475K | Sell |
15,082
-6,452
| -30% | -$203K | 0.01% | 748 |
|
|
2022
Q1 | $989K | Sell |
21,534
-15,713
| -42% | -$722K | 0.02% | 557 |
|
|
2021
Q4 | $2.28M | Sell |
37,247
-13,512
| -27% | -$827K | 0.05% | 321 |
|
|
2021
Q3 | $3.79M | Sell |
50,759
-22,256
| -30% | -$1.66M | 0.1% | 211 |
|
|
2021
Q2 | $6.75M | Sell |
73,015
-10,684
| -13% | -$988K | 0.17% | 129 |
|
|
2021
Q1 | $7.43M | Buy |
83,699
+22,285
| +36% | +$1.98M | 0.21% | 107 |
|
|
2020
Q4 | $5.73M | Buy |
61,414
+28,531
| +87% | +$2.66M | 0.17% | 134 |
|
|
2020
Q3 | $2.1M | Buy |
32,883
+21,966
| +201% | +$1.4M | 0.07% | 255 |
|
|
2020
Q2 | $569K | Buy |
+10,917
| New | +$569K | 0.02% | 551 |
|
|
2018
Q4 | – | Sell |
-140
| Closed | -$5K | – | 938 |
|
|
2018
Q3 | $5K | Buy |
+140
| New | +$5K | ﹤0.01% | 2426 |
|
|
2018
Q2 | – | Sell |
-140
| Closed | -$4K | – | 1060 |
|
|
2018
Q1 | $4K | Buy |
+140
| New | +$4K | ﹤0.01% | 2656 |
|